SecBot SecBot
Insider Buy ·Filed Aug 5, 2026

PFE

PFIZER INC
BULLISH
Impact 5/10
Horizonweeks Processed2mo ago SEC0001225208-26-006943
Insider cluster: 1 insiders, $960K total
Actionable Insight ▲ Bullish

A director's $960K open-market buy post-earnings beat is a rare bullish signal for a mega-cap like Pfizer. Monitor for additional insider purchases and Q3 2026 earnings for confirmation of the growth narrative.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d ⚠ clustered
PFE ▲ +9.96% at T+20d
LONG call ✓ call won +9.96% · α vs SPY +9.36% · entry $26.20 → $28.81
Next anchor: T+60d tomorrow
Latest observation: T+55 +13.35% FF3 residual α
Entry = T+0 close
Aug 5, 2026
via day close
T+1d
+2.14%
call +2.14% · α +1.53%
$26.76
settled 3mo ago
T+5d
+2.29%
call +2.29% · α +1.08%
$26.80
settled 3mo ago
T+20d
+9.96%
call +9.96% · α +9.36%
$28.81
settled 8w ago
T+60d
Pending
tomorrow

Price Chart

Loading chart...

Executive Summary

Pfizer director Mortimer J. Buckley made a $960K open-market purchase of 37,600 shares at $25.52 on August 5, 2026. This conviction buy follows Pfizer's Q2 2026 earnings beat and raised revenue guidance, signaling insider confidence in the company's post-COVID growth trajectory.

Key Financial Metrics

Direction
buying
Total Value
$960.0K
Insiders
1

Key Facts

  • Director Mortimer J. Buckley purchased 37,600 shares on the open market for $960,000 at $25.52 per share on August 5, 2026.
  • Purchase follows Pfizer's Q2 2026 earnings beat (adjusted EPS $0.77 vs $0.68 consensus) and raised FY2026 revenue guidance to $60.5-$62.5B.
  • The $960K purchase represents approximately 0.0006% of Pfizer's ~$140B market cap, a modest but notable insider signal.
  • CEO Albert Bourla was granted 24 shares on July 31, 2026, a routine non-cash award.

Financial Impact

$960,000 open-market purchase by a director at $25.52 per share

insider ownershipmarket sentiment

Risk Factors

  • Single insider purchase, not a cluster — signal strength is lower than a multi-insider buying spree.
  • Pfizer's GAAP net loss of $0.04 per share due to $4.3B in intangible asset impairments remains a concern.

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001225208-26-006943
18 reports for PFE
Performance horizon
57% Hit rate @ T+20 4 of 7 directional calls Went positive at some point 5 of 7 best @ T+20▲ +12.36%Aug 4, 2026
Filters
Rows
Reports for PFE — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
Institutional Cluster
MIXED ★ 3/10
$30.03awaiting T+20—$29.75 (−0.95%)
Aug 13, 2026
10w ago
Court Ruling
NEUTRAL ★ 1/10
$26.79 $27.72▲ +3.47%▲ +5.46%$29.75 (+11.03%)
Aug 12, 2026
10w ago
Insider Buy
BULLISH ★ 5/10
$26.80 $27.72▲ +3.43%▲ +5.18%$29.75 (+10.99%)
Aug 12, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$26.80 $27.72▲ +3.43%▲ +5.18%$29.75 (+10.99%)
Aug 6, 2026
11w ago
Insider Cluster
BULLISH ★ 4/10
$26.20 $28.81▲ +9.95%▲ +9.35%$29.75 (+13.53%)
Aug 5, 2026
11w ago
Insider Buy
BULLISH ★ 5/10
$26.20 $28.81▲ +9.96%▲ +9.36%$29.75 (+13.53%)
Aug 5, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.20 $28.81▲ +9.95%▲ +9.35%$29.75 (+13.53%)
Aug 4, 2026
12w ago
8-K
BULLISH ★ 7/10
$25.41 $28.55▲ +12.36%▲ +13.60%$29.75 (+17.06%)
Jul 31, 2026
12w ago
Court Ruling
BEARISH ★ 4/10
$25.03 $28.46▼ −13.70%▼ −12.47%$29.75 (−18.84%)
Jul 24, 2026
13w ago
Court Ruling
NEUTRAL ★ 1/10
$24.67 $27.97▲ +13.38%▲ +10.08%$29.75 (+20.57%)
Showing 10 of 18

US Market Status

Market Open — Closes in 3h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 5, 2026